OncologyPRO, in partnership with medwireNews, brings you updates each day in the field of medical oncology.
Watch leading oncology experts in ESMO's latest scientific and educational videos.
Collection of links to the latest cancer related articles in top medical journals: Annals of Oncology, The Lancet, JAMA, NEJM, BMJ and Nature Medicine
Haven't had much time lately? Here's what you may have missed in the last few months
Webcasts produced by leading oncology experts
New! Read patient cases produced by oncology experts or create and store your own cases
Find here all the information related to anti-cancer agents as described in the ESMO Handbook on Clinical Pharmacology of Anti-Cancer Agents.
Number of factsheets of validated biomarkers designed to assist you in your daily practice.
ESMO Clinical Trial Resources are designed to support you with designing, participating in and reviewing clinical trials
Find all ESMO 2014 abstracts classified by drug.
Find the most common oncology abbreviations.
Meeting reports from past ESMO organised and ESMO supported meetings.
Annotated links to the top biomarker journals related to oncology, as per the latest impact factor ranking and open access journals on biomarkers.
Educational slides on Cancer Prevention, Clinical Trials, Colorectal Cancer and Molecular Biology
The 2016 edition of ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology is now available
Our 2016 Clinical Practice Guidelines are now online.
Download the new version of our App with the latest Pocket Guidelines for professionals and Guides for Patients
Information, treatment algorithms and educational materials for healthcare professionals and patients about skin problems that may occur when being treated with anti-EGFR drugs
Information, treatment algorithms and educational materials for healthcare professionals and patients relating to the management of dermatological toxicities in patients treated with multikinase inhibitors.
Information and education online resource for healthcare professionals on drug-drug interactions which can arise from the use of kinase inhibitors
ESMO has developed a set of organ-specific tools designed to assist oncologists in their daily practice.
ESMO Consensus Conferences discuss key questions in certain disease areas and complement the ESMO Clinical Practice Guidelines
Useful information and updates created by ESMO for cancer patients
ESMO members: the recent ESMO Handbooks are available for browsing online to allow you to easily access the sections most relevant to you.
A simplified yet comprehensive overview on oncological malignancies, their biology, diagnosis, staging, treatment and follow-up, which are necessary for basic patient treatment
ESMO members: Browse through the ESMO Glossary in Molecular Biology of Cancer and Molecular Techniques online
Discover the User's Manual for Oncology Clinicians: “Clinician’s notes” for each of the 16 chapters of the patient guide.
Here, ESMO members can gain direct access to journals available to them for free (Annals of Oncology, Nature Reviews Cancer, Nature Reviews Clinical Oncology, and British Journal of Cancer). You can also find links to interesting journals in the fields of Medical Oncology, Haematology and Biomarkers.
Second-Line Regorafenib Boosts Advanced HCC Survival
CT Response-Related Tumour Parameters Linked To FIRE-3 OS Outcomes
Adjuvant Combination Therapy Improves Survival in Pancreatic Cancer
Second-Line Nanoliposomal Irinotecan Combination Promising In Metastatic Pancreatic Cancer
Fluoropyrimidine plus Bevacizumab Strong Maintenance Strategy For Metastatic CRC
Therapeutic Dual Inhibition of HER2 Pathway in the HERACLES Trial
Liver-Directed Therapy With SIRT, Using Y-90 Resin Microspheres, Plus FOLFOX-Based First-Line Chemotherapy for mCRC
Ramucirumab Results RAISE Metastatic CRC Overall Survival
CAIRO3 Supports Capecitabine, Bevacizumab Maintenance Therapy in Metastatic CRC
TAS-102 Improves Overall- and Progression-Free Survival in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies
Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage
Continuous versus intermittent chemotherapy strategies in metastatic colorectal cancer: a systematic review and meta-analysis
Smarter drugs emerging in pancreatic cancer therapy
Second-line chemotherapy in advanced biliary cancer: a systematic review
Immunological off-target effects of standard treatments in gastrointestinal cancers
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials
Right or Left met colon cancer: The impact of tumour side on treatment efficacy
Resistance to EGFR therapies in colorectal cancer
Targeting important pathways in gastric cancer: focus on VEGFR2
BRAF mutant colorectal cancer: current scenario and future perspectives
ESMO Preceptorship on Gastric Cancer 2015 (Singapore)
ESMO Preceptorship on Colorectal Cancer 2015 (Vienna)
ESMO Preceptorship on Gastric Cancer 2015
ESMO Preceptorship on Colorectal Cancer 2015
ESMO 2014 - Gastrointestinal tumours, colorectal
ESMO 2014 - Gastrointestinal tumours, non-colorectal
International Symposium on the Advances and Perspectives in Gastrointestinal Oncology
World GI 2014: abstracts, presentations and webcasts
Preceptorship on Colorectal Cancer 2014
Gastrointestinal Tract Tumours: Essentials for Clinicians
2015 European Cancer Congress – Scientific Meeting Report Gastrointestinal Cancers Extract
ESMO 2014 Congress Scientific Meeting Report - Gastrointestinal Cancers Extract
Current issues in the management of hepatocellular carcinoma
ESMO Consensus Conference on Colorectal Cancer
Colorectal cancer in the elderly: A chapter from ESMO Handbook of cancer in the senior patient
Microsatellite Instability - Defective DNA Mismatch Repair: ESMO Biomarker Factsheet
BRAF in Colorectal Cancer: ESMO Biomarker Factsheet
RAS in Colorectal Cancer: ESMO Biomarker Factsheet
HER2 in Gastric Cancer: ESMO Biomarker Factsheet
Personalised medicine in upper GI cancers
Cancer of the Pancreas
Metastatic colorectal cancer
Familial risk – colorectal cancer
Early colon cancer
Perioperative Treatment of Locally Advanced Rectal Cancer
MRI: Impact on rectal cancer care and standardisation
Optimising Outcomes in Gastrointestinal Neuroendocrine Tumours
Optimising the Assessment and Therapy of Oesophago-Gastric Junction Adenocarcinomas
Optimising outcomes for patients with advanced colorectal cancer
Optimising Anti-Angiogenic Strategies in Gastric Adenocarcinoma
Colorectal Cancer in Young Adults: The Focus on Hereditary Cancer Syndromes
Advances in Gastric Cancer: Biology and Treatment for Advanced Disease
Advances in Gastric Cancer: How to Approach Localised Disease
Validated and Promising Predictive Factors in mCRC: Recent Updates on RAS Testing
A Look to the Future in the Management of Metastatic and Locally Advanced Gastric Cancer
Access test questions